T6129 |
GSK-1070916
|
942918-07-2
|
98.51%
|
|
GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM. It displays >100-fold selectivity against the ...
|
T3863 |
Chikusetsusaponin IVa
|
51415-02-2
|
98.46%
|
|
Chikusetsusaponin IVa (Calenduloside F) is a novel AMPK activator, can induce insulin secretion from βTC3 cells via GPR4 mediated calcium and PKC pathways, may b...
|
T6854 |
GSK621
|
1346607-05-3
|
98.44%
|
|
GSK621 is a specific and potent AMPK activator.
|
T6S1784 |
Brazilin
|
474-07-7
|
98.31%
|
|
1. Brazilin (Braziletto) exhibits anti-hepatotoxic, antiplatelet effects. 2. Brazilin has cancer preventive effect, may inhibit T24 cell growth and trigger cell ...
|
TN2346 |
Mogrol
|
88930-15-8
|
98.21%
|
|
Mogrol, a biometabolite of mogrosides, functions by inhibiting the ERK1/2 and STAT3 pathways, diminishing CREB activation, and activating AMPK signaling.
|
TN1440 |
Beta-Hydroxyisovalerylshikonin
|
7415-78-3
|
98.16%
|
|
Beta-Hydroxyisovalerylshikonin is an inhibitor of protein-tyrosine kinases such as v-Src and EGFR, and has been shown to induce apoptosis in several human tumor ...
|
T4427 |
PF-06409577
|
1467057-23-3
|
98.16%
|
|
PF-06409577 is an effective, orally active, and specific allosteric activator of AMPK (EC50: 7 nM, for α1β1γ1).
|
T15137 |
DK419
|
2102672-22-8
|
98.15%
|
|
DK419 is an orally active inhibitor of Wnt/β-catenin signaling, with an IC50 of 0.19 μM. DK419 decreases protein lelvels of Axin2, β-catenin, c-Myc, Cyclin D1 an...
|
T13368 |
YLF-466D
|
1273323-67-3
|
98.04%
|
|
YLF-466D (C24) is a newly developed AMPK activator, which inhibits platelet aggregation.
|
T2133 |
Adenosine monophosphate
|
61-19-8
|
98.04%
|
|
Adenosine monophosphate (AMP) is a purine ribonucleoside 5'-monophosphates and a key cellular metabolite in signal transduction and regulation of energy homeosta...
|
T16156 |
MT 63-78
|
1179347-65-9
|
98.03%
|
|
MT 63-78 is a specific and effective direct AMPK activator (EC50: 25 μM). MT 63-78 blocks prostate cancer growth by inhibiting the lipogenesis and mTORC1 pathway...
|
T1477 |
AICAR
|
2627-69-2
|
98.00%
|
|
AICAR (NSC105823) is an AMP-activated protein kinase activator which is used for the treatment of acute lymphoblastic leukemia and may have applications in treat...
|
T7535 |
RGX-202
|
353-09-3
|
98%
|
|
RGX-202 (β-GPA) is a creatine analog that alters skeletal muscle energy expenditure. It reduces cellular ATP, creatine, and phosphocreatine levels and stimulates...
|
T7327 |
7-Methoxyisoflavone
|
1621-56-3
|
98%
|
|
7-Methoxyisoflavone is an activator of adenosine monophosphate-activated protein kinase (AMPK).
|
T20029 |
Buformin hydrochloride
|
1190-53-0
|
97.83%
|
|
Buformin hydrochloride (NSC-528218) is a potent AMPK activator,an oral antidiabetic drug of the biguanide class. Buformin delays the absorption of glucose from t...
|
T9010 |
IMM-H007
|
1221412-23-2
|
97.73%
|
|
IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expression
|
T0853L |
Adenosine 5'-monophosphate monohydrate
|
18422-05-4
|
97.68%
|
|
Adenosine 5'-monophosphate monohydrate (5'-AMP) , also known as 5'-adenylic acid, is a nucleotide that is used as a monomer in RNA. It is an ester of phosphoric ...
|
TN1702 |
Glycycoumarin
|
94805-82-0
|
97.64%
|
|
Glycycoumarin is an estrogen agonist, it shows moderate inhibitory effects against CYP1A2 and CYP2B6.
|
T60128 |
N,N-Didesethyl Sunitinib Hydrochloride
|
873077-70-4
|
97.1%
|
|
N,N-Didesethyl Sunitinib Hydrochloride is a potent AMPK inhibitor with IC50 of 393 nM and 141 nM for AMPKα1 and AMPK2,respectively.
|
T24626 |
PF-249
|
1467059-70-6
|
97.02%
|
|
PF-249 (PF-06685249) is a β1-selective AMPK with an EC50 of 12 nM for AMPK α1β1γ1 and can be used in studies about diabetic nephropathy.
|